
Amanda R. (Robinson) Kirane MD
Surgical Oncology (Other than Breast)
Director of Cutaneous Surgical Oncology and Assistant Professor of Surgical Oncology
Join to View Full Profile
300 Pasteur DrPalo Alto, CA 94304
Phone+1 650-723-4000
Dr. Kirane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an assistant professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine.
Her clinical practice focuses on the diagnosis and treatment of melanoma and other skin cancers. She partners closely with patients and families to provide the most effective treatment approach possible. For each patient, she tailors an evidence-based, personalized care plan that is innovative, comprehensive, and compassionate.
Dr. Kirane has conducted extensive research and been the principal investigator of multiple studies in melanoma and associated malignancies. Her current interests include immune response and novel therapies in melanoma. She has led research into immune therapy for melanoma that is resistant to current standards of care.
The National Institutes of Health, American Society of Clinical Oncology, and others have funded her research. She has co-authored articles on her discoveries in the Journal of Dermatological Treatment, Journal of Surgical Oncology, Journal of Surgical Research, Annals of Surgery, and elsewhere. Topics include advances in non-surgical management of melanoma.
She also co-wrote the chapter on the management of soft tissue sarcoma in the textbook Current Surgical Therapy.
Dr. Kirane has presented updates on the management of melanoma and other cancers to her peers at meetings of the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer.
She has earned awards for her achievements in clinical care, research, and scholarship. The Society for Immunotherapy of Cancer, Society of Surgical Oncology, Memorial Sloan Kettering Cancer Center, and other prestigious organizations have honored her work.
Dr. Kirane is a fellow of the American College of Surgeons (FACS) and Society of Surgical Oncology (FSSO). She is a member of the Society for Immunotherapy of
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2014 - 2016
University of Texas Southwestern Medical CenterResidency, Surgery, 2006 - 2014
University of Texas Southwestern Medical SchoolClass of 2006
Certifications & Licensure
CA State Medical License 2016 - 2028
NY State Medical License 2014 - 2017
American Board of Surgery Surgery
American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- Predicting targeted- and immunotherapeutic response outcomes in melanoma with single-cell Raman spectroscopy and AI.Kai Chang, Mamatha Serasanambati, Baba Ogunlade, Hsiu-Ju Hsu, James Agolia
Biorxiv. 2026-03-12 - 1 citationsRewiring STAT signaling from the cell surface with Trikine immunotherapeutics.Grayson E Rodriguez, Yang Zhao, Yoko Nishiga, Frank Peprah, Jiao Shen
Science. 2026-02-19 - 1 citationsDisruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma.Maria Korah, Rosyli F Reveron-Thornton, Mahsa Fallah, Peter Y Xie, Amanda Gonçalves
Cell Reports. 2025-10-28
Journal Articles
- Tumor Symbiosis: Gastrointestinal Stromal Tumor as a Host for Primary Peritoneal MesotheliomaSudeep Banerjee, Adam M Burgoyne, Joel Baumgartner, Amanda Kirane, Grace Y Lin, Jason Sicklick, Journal of gastrointestinal surgery
- Size and Location Are the Most Important Risk Factors for Malignant Behavior in Resected Solitary Fibrous TumorsSepideh Gholami, Amanda Kirane, Murray Brennan, Annals of Surgical Oncology
Press Mentions
New Insights Reveal Predictive Markers for Skin Cancer Patients’ Response to ImmunotherapyJanuary 8th, 2025
Skin Cancer: New Moderna Vaccine Shows Promise for Melanoma TreatmentDecember 19th, 2022
UC Davis Media Sources for Warm-Weather SafetyMay 23rd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









